Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

71 trials with published results (20%)

Research Maturity

212 completed trials (61% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.6%

16 terminated out of 348 trials

Success Rate

93.0%

+6.5% vs benchmark

Late-Stage Pipeline

24%

83 trials in Phase 3/4

Results Transparency

33%

71 of 212 completed with results

Key Signals

71 with results93% success16 terminated

Data Visualizations

Phase Distribution

205Total
Not Applicable (66)
Early P 1 (4)
P 1 (12)
P 2 (40)
P 3 (44)
P 4 (39)

Trial Status

Completed212
Unknown64
Recruiting28
Terminated16
Active Not Recruiting10
Not Yet Recruiting9

Trial Success Rate

93.0%

Benchmark: 86.5%

Based on 212 completed trials

Clinical Trials (348)

Showing 20 of 20 trials
NCT01852851Not ApplicableActive Not Recruiting

Employment and Arthritis: Making it Work

NCT02281747Active Not Recruiting

Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries

NCT04436640Phase 3Active Not Recruiting

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

NCT07390929Not ApplicableWithdrawnPrimary

Clinical Trial Study on the Improved New Method of Acupotomy for AS

NCT07534644Phase 1Not Yet RecruitingPrimary

A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis

NCT00085995CompletedPrimary

Progression of Spinal Fusion in Ankylosing Spondylitis

NCT05866614Active Not Recruiting

A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps

NCT06378697Phase 3CompletedPrimary

A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis

NCT05913817Completed

The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.

NCT07453628CompletedPrimary

Association of Erectile Dysfunction With Neuropathic Pain, Disease Activity, and Functional Status in Male Patients With Axial Spondyloarthritis: A Cross-Sectional Observational Study

NCT05792358Not ApplicableCompletedPrimary

Wet Cupping Therapy in Ankylosing Spondylitis

NCT06905288RecruitingPrimary

Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.

NCT05609643CompletedPrimary

Study to Assess Change in Disease Activity and Adverse Events of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan

NCT04402086Recruiting

Rheumatology Patient Registry and Biorepository

NCT07396194Not Yet RecruitingPrimary

Ankylosing Spondylitis

NCT07383805Not Yet RecruitingPrimary

Expression of Tim-3 on Neutrophils in Ankylosing Spondylitis

NCT07348939Not ApplicableCompletedPrimary

Effect Of Kinesiology Tape On Pain, Posture, Balance And Respiration In Ankylosing Spondylitis

NCT07329556Not Yet Recruiting

Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases

NCT06555562Not ApplicableCompleted

Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis

NCT05861102Phase 3Active Not RecruitingPrimary

Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)

Scroll to load more

Research Network

Activity Timeline